[1] |
Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum [J].Lancet, 1997, 350(9076): 485-487.
|
[2] |
Biró O, Rigó J Jr, Nagy B. Noninvasive prenatal testing for congenital heart disease-cell-free nucleic acid and protein biomarkers in maternal blood [J].J Matern Fetal Neonatal Med, 2020, 33(6): 1044-1050.
|
[3] |
Pös O, Biró O, Szemes T, et al. Circulating cell-free nucleic acids: characteristics and applications [J]. Eur J Hum Genet, 2018, 26(7): 937-945.
|
[4] |
Pös O, Budis J, Kubiritova Z, et al. Identification of structural variation from NGS-based non-invasive prenatal testing [J]. Int J Mol Sci, 2019, 20(18): 1-9.
|
[5] |
Mackie FL, Hemming K, Allen S, et al. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis [J]. BJOG, 2017, 124(1): 32-46.
|
[6] |
Pös O, Budiš J, Szemes T. Recent trends in prenatal genetic screening and testing [J]. F1000Res, 2019, 8(F1000 Faculty Rev): 1-10.
|
[7] |
Wang Y, Li S, Wang W, et al. Cell-free DNA screening for sex chromosome aneuploidies by non-invasive prenatal testing in maternal plasma [J]. Mol Cytogenet,2020,13(10): 1-8.
|
[8] |
王路明,周赤燕,胡月,等. 12085例无创产前基因检测在胎儿染色体异常筛查中的临床应用[J]. 中华医学遗传学杂志,2020,37(10): 1069-1073.
|
[9] |
杨勉,宋丰杰,姚岚. 无创产前基因检测在产前筛查和诊断中的应用效果观察[J].当代医学,2020,26(5): 122-124.
|
[10] |
Zheng Y, Wan S, Dang Y, et al. Non-invasive prenatal testing for detection of trisomy 13, 18, 21 and sex chromosome aneuploidies in 8594 cases [J]. Ginekol Pol, 2019, 90(5): 270-273.
|
[11] |
Bu J, Jiang P, Cui X, et al. Application values of prenatal screening and non-invasive gene sequencing in fetal birth defects [J]. Pak J Med Sci, 2020, 36(7): 1545-1549.
|
[12] |
郑芸芸,万陕宁,宋婷婷,等. 8594例孕妇无创DNA产前检测在胎儿染色体非整倍体疾病筛查中的临床应用[J]. 实用妇产科杂志,2019, 35(01): 68-71.
|
[13] |
Faas BH, de Ligt J, Janssen I, et al. Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells [J]. Expert Opin Biol Ther, 2012, 12 Suppl 1: S19-26.
|
[14] |
Wegrzyn P, Faro C, Falcon O, et al. Placental volume measured by three-dimensional ultrasound at 11 to 13+6 weeks of gestation: relation to chromosomal defects [J]. Ultrasound Obstet Gynecol, 2005, 26(1): 28-32.
|
[15] |
葛婷婷,孙庆梅,吴菊,等. 12807例孕早期唐氏筛查的临床应用现状分析[J]. 中国优生与遗传杂志,2018, 26(06): 27, 54-55.
|
[16] |
Yu D, Zhang K, Han M, et al. Noninvasive prenatal testing for fetal subchromosomal copy number variations and chromosomal aneuploidy by low-pass whole-genome sequencing [J]. Mol Genet Genomic Med, 2019, 7(6): 1-11.
|
[17] |
Chen Y, Yu Q, Mao X, et al. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 42,910 single pregnancies with different clinical features [J]. Hum Genomics, 2019, 13(1): 1-8.
|
[18] |
罗丽双,孟繁杰,郝冬梅,等. 4204例高龄孕妇的无创产前基因检测结果分析[J].生殖医学杂志,2020, 29(4): 532-535.
|
[19] |
叶燕绸,章钧. 应用孕妇血浆胎儿游离DNA进行无创产前检测的研究[J/CD].中华产科急救电子杂志,2017,6(04): 223-227.
|
[20] |
彭司琪,郭雅兰,李燕,等. 母体血浆胎儿游离DNA Rh D基因型产前诊断检测[J].实用预防医学,2018, 25(7): 880-883.
|
[21] |
程芳,马冬,范扶民,等. 正常孕妇血浆中cffDNA含量变化的研究[J].中国妇幼保健,2014, 29(20): 3333-3335.
|